Now showing items 60-79 of 315

    Descubrimiento de fármacos contra la enfermedad de Alzheimer basados en la estabilidad de la transtiretina 

    Cotrina Celis, Ellen Yadira (Date of defense: 2021-07-06)

    La enfermedad de Alzheimer es la principal causa de demencia. Es una enfermedad neurodegenerativa para la cual no existe tratamiento curativo. La transtiretina (TTR) es una proteína tetramérica conocida por su función ...

    Desenvolupament i recerca de formulacions per a vacunes veterinàries 

    Pi i Boleda, Berta (Date of defense: 2019-12-18)

    INTRODUCCIÓ: Aquesta tesi doctoral està inclosa dins del Pla de Doctorats Industrials de la Generalitat de Catalunya i s’ha realitzat conjuntament entre la Universitat de Barcelona i una empresa veterinària privada: ...

    Desenvolupament, caracterització i avaluació d’una nova forma farmacèutica basada en micro-comprimits d’alliberació modificada 

    Ruiz Xivillé, Núria (Date of defense: 2019-10-07)

    El metilfenidat HCl (MPH) és un fàrmac clàssic per al tractament del TDAH en nens a partir dels 6 anys, quan altres mesures resulten insuficients. Aquest trastorn es manifesta principalment durant la infància i l’adolescència ...

    Design and characterization of topical ketorolac tromethamine formulations 

    El Moussaoui El Masnaoui, Salima (Date of defense: 2022-10-26)

    [eng] Pain and inflammation are the most common and recurrent side effects after surgery and, understandably, the patient's most feared, affecting treatment adherence. The present work aims to characterize in vitro, ex ...

    Design and synthesis of engineered peptides to target undruggable PPIs: from in silico to in vitro studies 

    Rivas Santos, Pep (Date of defense: 2019-12-10)

    Major unsolved diseases such as Cancer, cardiopathies or neurodegenerative disorders are frequently related with the malunction of complex protein networks. These networks are integrated by the interaction of multiple ...

    Design and synthesis of new potentially inhibitors of PCSK9 and KRAS proteins 

    Vilaplana Saiz, Marta (Date of defense: 2021-01-22)

    This thesis shows the research carried out on two specific diseases: familial hypercholesterolemia, which is included within the cardiovascular diseases group, and cancer. These diseases are the major cause of deaths in ...

    Design, synthesis and biological evaluation of novel molecules with the capacity of inducing the degradation of different proteins by direct signaling to the proteasome 

    Alqahtani, Abdulateef (Date of defense: 2023-10-25)

    [eng] In 2001, the initial hypothesis of targeted protein degradation (TPD) was born to announce the launching of a new era of therapeutics development not by inhibiting a component of ubiquitin-proteasome system as small ...

    Design, synthesis and biological evaluation of photoswitchable molecules targeting G protein-coupled receptors in retina 

    González Díez, Aleix (Date of defense: 2023-07-24)

    [eng] G protein-coupled-receptors (GPCRs) are the largest family of membrane proteins and mediate important cellular responses. Metabotropic glutamate receptors (mGlu) belong to the Glutamate family/Class C GPCR. These ...

    Determinants de pèrdua de pes en persones amb obesitat intervingudes amb tècniques bariàtriques endoscòpiques. Desenvolupament i validació d’un nou qüestionari curt d’hàbits saludables d’alimentació i d’activitat física 

    Miranda Peñarroya, Maria Gemma (Date of defense: 2022-11-28)

    [cat] Les teràpies endoscòpiques bariàtriques (TEB) són estratègies prometedores per al tractament de l'obesitat. No obstant això, hi ha una gran variabilitat en la pèrdua de pes i els individus sovint recuperen el pes ...

    Development and application of in-vitro assays for the study of the biological activity of pharmaceutical products 

    Cañellas Santos, Mariona (Date of defense: 2022-11-03)

    [eng] This industrial Ph.D. thesis aimed to illustrate the presence of the cell-based bioassays throughout the whole life of a drug product and to demonstrate its importance for a complete characterization of a pharmaceutical ...

    Development and applications of photoswitchable ligands for G protein-coupled receptors 

    Sortino, Rosalba (Date of defense: 2023-10-18)

    [eng] G protein-coupled receptors (GPCRs) modulate diverse cellular responses to the majority of neurotransmitters and hormones within the human body. They exhibit much structural and functional diversity and are responsive ...

    Development and characterization of in vivo models for Photopharmacology 

    Gomila Juaneda, Alexandre (Date of defense: 2021-09-20)

    The main aim of this thesis is setting up and using in vivo screening techniques to identify and characterize new photopharmacological compounds targeting endogenous proteins. In order to achieve that aim, the thesis ...

    Development and characterization of solid lipid nanoparticles (SLN) as a vehicle of biomolecules 

    Bustos Araya, Marta Eduviges (Date of defense: 2023-02-24)

    [eng] The interest of this work was to manufacture solid lipid nanoparticles that serve as a vehicle for biomolecules, specifically Chondroitin sulfate and pEGFP plasmid DNA. In the experimental part, the reagents and ...

    Development of crystallographic methods for phasing highly modulated macromolecular structures 

    Caballero Muñoz, Iracema (Date of defense: 2021-03-26)

    Pathologies that result in highly modulated intensities in macromolecular crystal structures pose a challenge for structure solution. To address this issue two studies have been performed: a theoretical study of one of ...

    Dietary (poly)phenols intake and cardiometabolic health in adolescents from Spain 

    Laveriano Santos, Emily Pilar (Date of defense: 2022-11-29)

    [eng] The rising of cardiometabolic risk factors like obesity, higher blood pressure, and alteration in the metabolism of lipids and glucose during adolescence increase the risk of type 2 diabetes mellitus and cardiovascular ...

    Dietary patterns and cardiomethabolic health 

    Rodríguez Monforte, Míriam (Date of defense: 2017-03-06)

    Las enfermedades cardiometabólicas son la primera causa de muerte a nivel mundial. La prevención primaria de dichas enfermedades es el pilar fundamental para una salud óptima de los adultos, debiendo empezar desde la ...

    Discovery of First-In-Class inhibitors of a DNA damage repair pathway 

    Camps i Fajol, Cristina (Date of defense: 2022-12-19)

    [eng] Cancer is the second leading cause of death globally. The gold standard for cancer has historically been surgery, radiotherapy and chemotherapy. Although the efficacy of chemotherapy has been broadly confirmed, drug ...

    Diseño y caracterización de nanopartículas poliméricas de Epigalocatequina-3-galato para el tratamiento de enfermedades del sistema nervioso central 

    Cano Fernández, Amanda (Date of defense: 2018-11-09)

    Las enfermedades del sistema nervioso central (SNC) engloban a un conjunto de patologías de elevada gravedad debido a la importancia de este sistema para el organismo. La Epilepsia del Lóbulo Temporal (TLE) y la Enfermedad ...

    Disrupció de l’homeòstasi lipídica com estratègia terapèutica en leucèmia limfoblàstica aguda -T 

    Banús Mulet, Antònia (Date of defense: 2019-07-16)

    Recentment s’han descrit els receptors de dopamina per la seva implicació en càncer i la seva potencial inhibició com a mecanisme antitumoral. Al present treball s’ha ampliat aquesta recerca a la LLA-T, una malaltia amb ...

    Disrupted homeostasis and ciliary defects in VPS13B deficient cells: implications for Cohen syndrome 

    Lovera Ulecia, Marta (Date of defense: 2023-05-05)

    [eng] Cohen syndrome (CS) is an ultra-rare, multi-system, autosomal recessive disorder caused by mutations in the VPS13B gene on chromosome 8q22.2. The most characteristic clinical features of this disorder are microcephaly, ...